8-K: Monogram Technologies Terminates Key License Agreement, Issues New Preferred Stock for $4 Million Settlement

Monogram Technologies Inc. has terminated its exclusive license agreement with Icahn School of Medicine at Mount Sinai, settling the obligation with a $4 million payment comprising cash and newly issued Series E Preferred Stock.

Summary

• Monogram Technologies Inc. terminated its Exclusive License Agreement with Icahn School of Medicine at Mount Sinai, effective July 10, 2025.
• A total payment of $4,000,000 was made to Mount Sinai for the termination, consisting of $500,000 in cash and 35,000 shares of newly created Series E Preferred Stock.
• The Series E Preferred Stock has an aggregate liquidation preference of $3,500,000, is perpetual, and ranks senior to common stock and pari passu to the company's 8.00% Series D Convertible Cumulative Preferred Stock.
• Holders of Series E Preferred Stock will receive cumulative dividends at an annual rate of 10.00% of the $100 per share liquidation preference, beginning July 1, 2026, payable quarterly.
• Mandatory redemption provisions for Series E Preferred Stock are triggered if the company raises at least $25,000,000 in gross cash proceeds from securities offerings, or if a person/group acquires 40% or more of the company's combined voting power.
• A partial redemption mechanism is also in place, requiring 15% of gross cash proceeds between $10,000,000 and $25,000,000 from future offerings to be used for pro rata redemption of Series E Preferred Stock.
• Series E Preferred Stock is convertible into common stock at the holder's option on or after July 1, 2026, with the conversion rate based on the common stock's 20-day volume weighted average price (VWAP).
• The issuance of the Series E Preferred Stock was conducted as an unregistered sale of equity securities pursuant to Section 4(a)(2) and/or Rule 506 of the Securities Act of 1933.

Sentiment

Score: 4

Explanation: The termination of a material agreement with a significant payment and the issuance of new preferred stock with senior rights and cumulative dividends are generally negative for common shareholders, indicating a cost and future financial obligations. While resolving an agreement can be positive, the terms of resolution appear costly and introduce new liabilities.

Positives

• Resolution of a material definitive agreement, potentially removing ongoing obligations or uncertainties associated with the prior License Agreement.
• The new Series E Preferred Stock structure includes mechanisms for future capital raises to trigger redemptions, potentially offering an exit for preferred shareholders and simplifying the capital structure over time.

Negatives

• A significant payment of $4,000,000 ($500,000 cash and $3,500,000 in preferred stock) was incurred for the termination of a license agreement, representing a direct cost to discontinue intellectual property rights.
• The company lost rights and licenses to certain specified intellectual property previously licensed from Mount Sinai.
• The issuance of new Series E Preferred Stock introduces a class of securities that ranks senior to common stock in liquidation and carries a substantial 10% cumulative dividend obligation starting July 1, 2026, which could dilute common shareholders or strain future cash flow.
• Series E Preferred Stock holders do not have voting rights, limiting their influence on corporate matters despite their senior financial position.

Risks

• Dilution Risk: Future conversion of Series E Preferred Stock into common stock could dilute existing common shareholders.
• Liquidation Preference: Series E Preferred Stock ranks senior to common stock in liquidation, meaning common shareholders would receive distributions only after preferred shareholders are paid their $100 per share liquidation preference plus accrued dividends.
• Dividend Obligation: The 10% cumulative dividend on Series E Preferred Stock, starting July 1, 2026, creates a fixed financial obligation that could impact the company's profitability and cash flow, especially if paid in cash.
• Capital Structure Complexity: The introduction of another series of preferred stock (Series E, pari passu to Series D) adds complexity to the company's capital structure.
• Loss of Intellectual Property: The termination of the License Agreement means the company no longer has rights to the specified intellectual property from Mount Sinai, which could impact future product development or strategic direction if that IP was critical.

Future Outlook

The company has established a new class of preferred stock (Series E) with specific redemption triggers tied to future capital raises, indicating a potential strategy for future financing and managing the preferred stock's lifecycle. The ability for holders to convert to common stock after July 1, 2026, also points to a future shift in the capital structure.

Management Comments

• Monogram Technologies Inc. has caused this Certificate of Designation to be duly executed by its Chief Executive Officer, on this 11th day of July, 2025. (Signed by Benjamin Sexson, CEO)

Industry Context

NA

Corporate Governance

Stakeholder Impact

• Shareholders (Common Stock): Potential dilution from future conversion of Series E Preferred Stock; subordination in liquidation; potential impact on earnings per share due to cumulative preferred dividends.
• Mount Sinai: Received a $4,000,000 settlement ($500,000 cash + $3,500,000 in preferred stock) and regained rights to its intellectual property.
• Future Investors (Series E Preferred Stock): Gained a senior security with a fixed liquidation preference, cumulative dividends, and mandatory redemption/conversion options.

Next Steps

• Payment of $500,000 cash and delivery of 35,000 Series E Preferred Stock shares to Mount Sinai.
• Future quarterly dividend payments on Series E Preferred Stock beginning July 1, 2026.
• Potential future redemptions of Series E Preferred Stock based on capital raise thresholds or change of control events.
• Potential future conversions of Series E Preferred Stock into common stock by holders on or after July 1, 2026.

Key Dates

Recommendation

Keywords

Monogram Technologies, SEC Filing, 8-K, License Agreement Termination, Preferred Stock, Series E Preferred Stock, Capital Raise, Corporate Governance, Intellectual Property, Mount Sinai, Redeemable Preferred Stock, Convertible Preferred Stock, Financial Reporting